Kangstem Biotech Co. Ltd (217730) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.056x

Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has a cash flow conversion efficiency ratio of -0.056x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.47 Billion ≈ $-2.35 Million USD) by net assets (₩62.25 Billion ≈ $42.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 217730 net asset quality score to measure how much of total assets are equity-financed.

Kangstem Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Kangstem Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 217730 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Kangstem Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Esenboga Elektrik Uretim AS IS:ESEN	-0.041x
RF Industries Ltd NASDAQ:RFIL	0.024x
MC Mining Ltd AU:MCM	-0.090x
Shimmick Corporation Common Stock NASDAQ:SHIM	-0.011x
Samindo Resources Tbk JK:MYOH	0.064x
Horizon Gold Ltd AU:HRN	-0.016x
Lonyer Fuels SHG:603003	0.026x
Siam Wellness Group Public Company Limited BK:SPA	0.119x

Annual Cash Flow Conversion Efficiency for Kangstem Biotech Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Kangstem Biotech Co. Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Kangstem Biotech Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩69.06 Billion ≈ $46.80 Million	₩-11.68 Billion ≈ $-7.91 Million	-0.169x	+61.55%
2024-12-31	₩43.18 Billion ≈ $29.26 Million	₩-18.99 Billion ≈ $-12.87 Million	-0.440x	-18.65%
2023-12-31	₩44.52 Billion ≈ $30.17 Million	₩-16.50 Billion ≈ $-11.18 Million	-0.371x	+7.15%
2022-12-31	₩47.26 Billion ≈ $32.03 Million	₩-18.86 Billion ≈ $-12.78 Million	-0.399x	-59.89%
2021-12-31	₩68.07 Billion ≈ $46.13 Million	₩-16.99 Billion ≈ $-11.52 Million	-0.250x	+7.92%
2020-12-31	₩51.62 Billion ≈ $34.98 Million	₩-13.99 Billion ≈ $-9.48 Million	-0.271x	-43.92%
2019-12-31	₩70.72 Billion ≈ $47.93 Million	₩-13.32 Billion ≈ $-9.03 Million	-0.188x	+21.73%
2018-12-31	₩47.69 Billion ≈ $32.32 Million	₩-11.48 Billion ≈ $-7.78 Million	-0.241x	+46.94%
2017-12-31	₩23.47 Billion ≈ $15.91 Million	₩-10.65 Billion ≈ $-7.22 Million	-0.454x	-33.67%
2016-12-31	₩22.98 Billion ≈ $15.57 Million	₩-7.80 Billion ≈ $-5.28 Million	-0.339x	-89.64%
2015-12-31	₩21.24 Billion ≈ $14.39 Million	₩-3.80 Billion ≈ $-2.58 Million	-0.179x	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$134.49 Million

₩198.45 Billion KRW

Market Cap Rank

#18015 Global

#742 in Korea

Share Price

₩2110.00

Change (1 day)

-6.22%

52-Week Range

₩1171.00 - ₩4615.00

All Time High

₩18836.30